H1 is a health technology platform that aims to empower stakeholders at healthcare and life science companies to make smarter decisions using data. With a mission to connect doctors to the most relevant research information, the company offers tools like the AI-powered medical affairs and MSL platform, an investigative trial landscape, and provider data management for healthcare. H1 was founded in 2017 by Ariel Katz and Ian Sax and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/09/2022 | Series C | $120.96MM | $xx.xx | $773.23MM | Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital | |
Price per Share
$xx.xx
Shares Outstanding
5,049,470
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital
|
||||||
12/17/2020 | Series B-2 | $169,623.38 | $xx.xx | $247.41MM | Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
53,672
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
|
||||||
12/17/2020 | Series B-1 | $57.85MM | $xx.xx | $247.41MM | Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
6,412,544
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
|
||||||
04/22/2020 | Series A-3 | $150,007.62 | $xx.xx | $35.49MM | Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
955,280
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
|
||||||
04/22/2020 | Series A-2 | $585,004.00 | $xx.xx | $35.49MM | Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
309,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
|
||||||
04/22/2020 | Series A-1 | $12.98MM | $xx.xx | $35.49MM | Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
5,493,762
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
|